Product NDC: | 55513-283 |
Proprietary Name: | EPOGEN |
Non Proprietary Name: | epoetin alfa |
Active Ingredient(s): | 10000 [iU]/mL & nbsp; epoetin alfa |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55513-283 |
Labeler Name: | Amgen Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103234 |
Marketing Category: | BLA |
Start Marketing Date: | 19941205 |
Package NDC: | 55513-283-10 |
Package Description: | 10 VIAL in 1 PACKAGE (55513-283-10) > 2 mL in 1 VIAL (55513-283-01) |
NDC Code | 55513-283-10 |
Proprietary Name | EPOGEN |
Package Description | 10 VIAL in 1 PACKAGE (55513-283-10) > 2 mL in 1 VIAL (55513-283-01) |
Product NDC | 55513-283 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epoetin alfa |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19941205 |
Marketing Category Name | BLA |
Labeler Name | Amgen Inc |
Substance Name | ERYTHROPOIETIN |
Strength Number | 10000 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |